Pal-ing, Jeneva M.

HRN: 26-79-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2025
CEFTRIAXONE 1G (VIAL)
03/15/2025
03/23/2025
IV
2gms
Od
None
Waiting Final Action 
03/21/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/21/2025
03/28/2025
PO
30ml
TID
SLE
Waiting Final Action 
03/21/2025
COTRIMOXAZOLE 960MG (TAB)
03/21/2025
03/28/2025
PO
800/160
MWF
Sle
Waiting Final Action 
03/30/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/30/2025
04/07/2025
IV
500 G
Q48
Hap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: